Catarina Mendes Silva

Preclinical and clinical trials for vaccine induction of CD4-binding site-neutralizing antibodies.

Progress toward a protective CD4bs-directed HIV-1 vaccine will require further optimization of adjuvants, delivery systems, and sequential immunogen design to balance precursor recruitment with structural constraint and to sustain affinity maturation across multidose regimens.